Officinalisinin I

Officinalisinin I
Product Name Officinalisinin I
CAS No.: 57944-18-0
Catalog No.: CFN90692
Molecular Formula: C45H76O19
Molecular Weight: 921.07 g/mol
Purity: >=98%
Type of Compound: Steroids
Physical Desc.: Powder
Source: The rhizomes of Anemarrhena asphodeloides Bunge
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $248/20mg
Officinalisinin Ⅰcan effectively reduce the blood glucose and protect nerve injuryin diabetic mice.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Biomed Chromatogr.2019, 8:e4774
  • Evid Based Complement Alternat Med.2017, 2017:9764843
  • Food Analytical Methods2020, 13,1603-1612(2020)
  • Molecules2022, 27(12):3824.
  • Plant J.2021, 107(6):1711-1723.
  • United States Patent Application2020, 20200038363
  • Biosci Biotechnol Biochem.2020, 84(3):621-632
  • Ind Crops Prod.2015, 67:185-191
  • J Tradit Chin Med.2023, 43(6):1081-1091.
  • Sci Rep.2019, 9(1):4646
  • Anemarsaponin BIII

    Catalog No: CFN90778
    CAS No: 142759-74-8
    Price: Inquiry(manager@chemfaces.com)
    Timorsaponin C

    Catalog No: CFN90779
    CAS No: 185432-00-2
    Price: Inquiry(manager@chemfaces.com)
    Parisyunnanoside B

    Catalog No: CFN90704
    CAS No: 945865-37-2
    Price: $318/10mg
    Pseudoprotodioscin

    Catalog No: CFN90694
    CAS No: 102115-79-7
    Price: $138/20mg
    Dioscoreside C

    Catalog No: CFN95345
    CAS No: 344912-80-7
    Price: $318/5mg
    Dioscoreside E

    Catalog No: CFN95346
    CAS No: 435321-73-6
    Price: $318/5mg
    Terrestrosin K

    Catalog No: CFN90822
    CAS No: 193605-07-1
    Price: $218/10mg
    Pseudoproto Pb

    Catalog No: CFN90705
    CAS No: 102100-46-9
    Price: Inquiry(manager@chemfaces.com)
    Officinalisinin I

    Catalog No: CFN90692
    CAS No: 57944-18-0
    Price: $248/20mg
    Anemarsaponin E

    Catalog No: CFN99533
    CAS No: 136565-73-6
    Price: $308/10mg
    China Journal of Traditional Chinese Medicine & Pharmacy, 2017 (2) :782-785.
    Study on hypoglycemic mechanism and central nerve protection of Officinalisinin Ⅰ in Rhizoma Anemarrhenae[Reference: WebLink]
    To study the hypoglycemic effect of Officinalisinin Ⅰin Rhizoma Anemarrhenae on diabetes, and discuss the hypoglycemic mechanism and protective effect on diabetic nephropathy.
    METHODS AND RESULTS:
    Glucose tolerance was measured in model mice induced by oral administration of alloxan.Inhibition of glycosidase activity was tested in vitro.GLP-1 was detected after fasting in diabetic mice.The levels of BDNF and GSH-PX in serum were detected by enzyme-linked immunosorbent assay(ELISA) after 20 days of medication.Officinalisinin I has the functions of lowering blood glucose and significantly improving the glucose tolerance of diabetic mice.In the experiment, the glycosidase inhibitor pathway was eliminated, andby promoting the generation of GLP-1 and BDNF and increasing the activity of GSH-PX Officinalisinin I achieves the hypoglycemic and neuroprotective effect.
    CONCLUSIONS:
    Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.
    Apterin

    Catalog No: CFN95005
    CAS No: 53947-89-0
    Price: $388/10mg
    6-Hydroxy-7-methoxydihydroligustilide

    Catalog No: CFN95289
    CAS No: 210036-09-2
    Price: $318/5mg
    Batatasin V

    Catalog No: CFN95320
    CAS No: 65817-45-0
    Price: $318/5mg
    Eucomic acid

    Catalog No: CFN95364
    CAS No: 42151-32-6
    Price: $368/5mg
    New compound 14

    Catalog No: CFN95381
    CAS No: N/A
    Price: $413/5mg
    Isogambogic acid

    Catalog No: CFN95440
    CAS No: 149655-52-7
    Price: $318/10mg
    Pinocembroside

    Catalog No: CFN95444
    CAS No: 75829-43-5
    Price: $118/20mg
    Senkyunolide N

    Catalog No: CFN95449
    CAS No: 140694-58-2
    Price: $318/10mg
    Kaempferol 3,5-O-diglucoside

    Catalog No: CFN95487
    CAS No: 205103-97-5
    Price: $318/10mg
    Octyl 3-(4-hydroxyphenyl)prop-2-enoate

    Catalog No: CFN95563
    CAS No: N/A
    Price: $318/5mg